Vendor comparison · 2026
L-Carnitine vendors: 5 compared on COAs and price
MetabolicAlso known as Levocarnitine
Evidence tier
Substantial published literature
3,523 publications over 73 years · trials not yet curated
- Vendors carrying it
- 5
- 5 with a listed price
- Vendors with checkable COAs
- 1
- 1 publish any certificate
- Lots tested
- 1
- 1 naming a checkable lab
- Independent assays
- 0
- none on file yet
- Newest assay
- 15 Jun 2026
- oldest 15 Jun 2026
- Laboratories named
- 1
- most often Freedom Diagnostics Testing
- Median label gap
- 81.8%
- 0% of lots within 5% of label
- Median purity
- 99.79%
- 1 of 1 lots at 99% or above
- Lowest price per mg
- $0.030
- peer median $0.090
- Publications located
- 3.5k
- researched since 1953
Source: PepIndex, an independent index of research-peptide vendors. No vendor can pay for a rank, every score is computed by a published formula, and every figure links to the document it was read from.
PeptidePlugs has the most checkable L-Carnitine testing in this index: 1 lot assayed by Freedom Diagnostics Testing, the newest on 15 Jun 2026. The lowest listed price is $0.030 per mg at PeptidePlugs, the same vendor, against a peer median of $0.090. 5 vendors carrying L-Carnitine are compared below. 1 publish at least one certificate naming a checkable laboratory, 1 lot record is on file, and none is an independently commissioned assay. Figures are PepIndex's own: it is an independent index of research-peptide vendors, no vendor can pay for a rank, and each figure links to the certificate it was read from.
Every vendor carrying L-Carnitine
| # | Vendor | Score here | Price / mg | Lots | Newest test | Laboratory | Mean purity | Label gap | Reports |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PeptidePlugs | 91.394% | $0.030 (33%) | 1 / 1 | Freedom Diagnostics Testing | 99.8% | 81.8% | ||
| 2 | Modern AminosISO/IEC 17025COAs need an account | 80.997% | $0.090 (100%) | 0 | — | — | — | — | no reportVisit site |
| 3 | Northline LabsISO/IEC 17025 | 79.395% | $0.100 (111%) | 0 | — | — | — | — | no reportVisit site |
| 4 | NeuroLabs Research | 78.691% | $0.100 (111%) | 0 | — | — | — | — | no reportVisit site |
| 5 | Eternal Peptides | 6263% | $0.090 (100%) | 0 | — | — | — | — | no reportVisit site |
Independent assays
No independently commissioned assay of L-Carnitine is on file. All 1 records below were published by the vendor that sells the product, naming the laboratory shown. PepIndex does not yet commission its own assays, so nothing on this page establishes what is in a vial beyond the vendor’s own certificate. A record moves into this section the moment an assay commissioned by anyone other than the seller is indexed.
What the certificates show
1 of 1 lots at 99% or above; median 99.79%.
| Range | lots |
|---|---|
| <95% | 0 |
| 95–97% | 0 |
| 97–98% | 0 |
| 98–99% | 0 |
| 99–99.5% | 0 |
| ≥99.5% | 1 |
0% of lots within 5% of the labelled mass; median gap 81.8%.
| Range | lots |
|---|---|
| ≤2% | 0 |
| 2–5% | 0 |
| 5–10% | 0 |
| 10–20% | 0 |
| >20% | 1 |
5 vendors, $0.030 to $0.100; median $0.090.
| Range | vendors |
|---|---|
| $0.020–$0.040 | 1 |
| $0.040–$0.060 | 0 |
| $0.060–$0.080 | 0 |
| $0.080–$0.100 | 4 |
Purity and mass are read from each certificate as published; the label gap is |labeled − assayed| ÷ labeled. Every value behind these bars is in the certificate table below.
Laboratories used
| Laboratory | Lots | Vendors | Share | Verify |
|---|---|---|---|---|
| Freedom Diagnostics TestingUS | 1 | 1 | 100% | Public lookup |
Every certificate record
| Vendor | Lot | Tested | Lab | Labeled | Assayed | Discrepancy | Purity | Report |
|---|---|---|---|---|---|---|---|---|
 PeptidePlugs | 137-01-SM | Freedom Diagnostics Testing | 1200 mg | 218.95 mg | 81.8% | 99.8% | Vendor-published |
Score breakdown
The score has two halves: the research base — how long the compound has been studied and how much has been published — and the quality of the evidence the market produces for it, aggregated across every vendor that carries it: assayed purity, lot-to-lot consistency, readable third-party certificates and those vendors’ review record. It measures the evidence base, not the merits or safety of the substance.
Studied since 1953 — 73 years of published research
How long the compound has been studied. Fifteen years or more of published literature earns full marks; a newer compound earns less.
3,523 publications indexed in PubMed
The volume of published literature located. Full marks at fifty or more publications.
Mean assayed purity 99.8% across 1 certificate
Average assayed purity on the certificates published by vendors that carry this compound. Full marks at 99.5%+, nothing at 95% or below.
single lot on record, mean label deviation 81.8%
How tightly assayed purity and labeled-versus-actual mass hold across different lots. Rewards reproducible manufacturing.
5 of 5 listing vendors publish an accessible certificate policy
Whether the vendors carrying this compound publish per-lot certificates anyone can read without an account.
1 of 1 certificate from a recognised independent lab
Share of certificates issued by a recognised third-party testing lab rather than an unnamed or self-named one.
What is L-Carnitine?
L-carnitine (levocarnitine), an amino-acid derivative central to the transport of fatty acids into mitochondria. It is available both as an approved medicine and as a dietary supplement and is extensively studied.
Studied in published research for fatty-acid metabolism, exercise and weight management.
Regulatory status
L-carnitine is an approved prescription medicine in one or more of the United States, United Kingdom and European Union. When listed by the vendors in this index it is labeled for laboratory research use only, and nothing here is medical advice or an endorsement of human use.
What the research examines
The areas of published research this compound appears in. These describe what the literature has studied — never a claim of benefit, effect or suitability for any use.
Published research
PepIndex records the size and shape of the published research footprint only. It does not evaluate or summarise clinical significance, does not describe administration, and nothing here is a claim of safety or efficacy.
- l-Carnitine Supplementation in Recovery after Exercise — Nutrients (2018)
Peer-reviewed article indexed in PubMed, published in Nutrients (2018).
- L-carnitine--metabolic functions and meaning in humans life — Current drug metabolism (2011)
Peer-reviewed article indexed in PubMed, published in Current drug metabolism (2011).
- Levocarnitine — PubMed-indexed journal (2006)
Peer-reviewed article indexed in PubMed, published in PubMed-indexed journal (2006).
- Propionyl-L-carnitine — Drugs & aging (1998)
Peer-reviewed article indexed in PubMed, published in Drugs & aging (1998).
- L-carnitine: to fuel or not to fuel the failing heart? — Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese (2020)
Peer-reviewed article indexed in PubMed, published in Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese (2020).
- Pharmacokinetics of L-carnitine — Clinical pharmacokinetics (2003)
Peer-reviewed article indexed in PubMed, published in Clinical pharmacokinetics (2003).
PepIndex describes what literature exists. We do not interpret it, assess clinical significance, or publish quantities, protocols or instructions for use.